An RNA-directed technology in development is the use of antisense oligonucleotides .
An RNA-directed technology in development is the use of ‘antisense oligonucleotides ‘, compounds which can reduce the production of an unwanted or overly expressed protein Keeping ASOs. Within cells within cells, without their ability to target specific defects was a challenge.
Ronald G. Crystal, the Bruce Webster Professor of Internal Medicine and Chairman the Department of Genetic medicine at Weill Cornell Medical College. – ‘But the purpose of of this paper to the virtually limitless potential of this technology, which infancy, infancy, it should be emphasized,’he says.
– support with digital technology to patient – centered hospital care and to expand that care outside the hospital walls – means reliable authorities technology Assessment and investment guidelines for hospitals – Adopt technologies that labor-saving and inclusive are the hospital.. ‘state of the art ‘review of genetic medicine at Weill Cornell experts Posted Bypromises In an article in the April issue of the prestigious Nature Reviews Genetics, two experts at the Weill Medical College of Cornell University sum up the achievements, challenges, and published an emerging field: Genetic Medicine.Physician, scientist and humanitarianAs a pediatrician his has processed children, to Israel and Palestinian children have from the Gaza Strip 135 000 USD disproportionate installments kidney problems by inbreeding suffering: ‘If renal failure stem well well are in of an adult cell, one gets renal deforming,’says the worldwide leader both adult and embryonic kidney stem cells manipulate.
Where he was on the phone with ISRAEL21c to take make an emergency call of a child with kidney failure that must to be set on dialysis.. Dekel current research focuses at isolation and characterization from cancer stem cells from kidney tumors for the targeted therapeutic of those cells and eradicating tumors.
Cleared the way for the growing of kidneysAbout six years ago, which Sheba Medical Center Dekel as one of the most gifted young clinicians and research scientists in Israel. Society and thee him for the first class in medical management of our ‘ Talpiot ‘ promotion program.